1-deoxynojirimycin has been researched along with puromycin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dishon, DS; Ferrell, GA; Le, A; Le, QQ; Sifers, RN | 1 |
Hara, K; Koide, T; Tokunaga, F | 1 |
2 other study(ies) available for 1-deoxynojirimycin and puromycin
Article | Year |
---|---|
Soluble aggregates of the human PiZ alpha 1-antitrypsin variant are degraded within the endoplasmic reticulum by a mechanism sensitive to inhibitors of protein synthesis.
Topics: 1-Deoxynojirimycin; 2,4-Dinitrophenol; alpha 1-Antitrypsin; Animals; Brefeldin A; Cycloheximide; Cyclopentanes; Dinitrophenols; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Glucosamine; Golgi Apparatus; Humans; Liver Neoplasms, Experimental; Mice; Nocodazole; Protein Synthesis Inhibitors; Puromycin; Transfection; Tumor Cells, Cultured | 1992 |
N-linked oligosaccharide processing, but not association with calnexin/calreticulin is highly correlated with endoplasmic reticulum-associated degradation of antithrombin Glu313-deleted mutant.
Topics: 1-Deoxynojirimycin; Alkaloids; Animals; Antithrombins; Calnexin; Calreticulin; Carbohydrate Conformation; Cells, Cultured; Cricetinae; Cycloheximide; Endoplasmic Reticulum; Enzyme Inhibitors; Glucosidases; Indolizines; Mannose; Mannosidases; Mutation; Oligosaccharides; Protein Synthesis Inhibitors; Protein Tyrosine Phosphatases; Puromycin | 2003 |